2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

251 - 

Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19

Florian Lemaitre, Klemens Budde, Teun van Gelder, Stein Bergan, Roland Lawson et al.

Therapeutic Drug Monitoring, 2023, 45 (2), pp.191-199.

DOI : https://doi.org/10.1097/FTD.0000000000001014

Pubmed : 35944126

 

252 - 

Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?

Florian Lemaitre, Virginie Florentin, Olivier Blin, Arnaud Bayle, Sylvain Bénito et al.

Therapies, 2023, Apie,

DOI : https://doi.org/10.1016/j.therap.2023.11.007

Pubmed : 38065821

 

253 - 

Immediate hypersensitivity to dupilumab: A French case series

Romain Lemery, Claire Cariou, Anne-Sophie Darrigade, Cécile Rochefort-Morel, Priscille Carvalho-Lallement et al.

Journal of Allergy and Clinical Immunology: In Practice, 2023, 11 (8), pp.2608-2610.

DOI : https://doi.org/10.1016/j.jaip.2023.04.043

Pubmed : 37178761

 

254 - 

Comparison between 5 extractions methods in either plasma or serum to determine the optimal extraction and matrix combination for human metabolomics

Maryne Lepoittevin, Quentin Blancart-Remaury, Thomas Kerforne, Luc Pellerin, Thierry Hauet et al.

Cellular and Molecular Biology Letters, 2023, 28 (1), pp.43.

DOI : https://doi.org/10.1186/s11658-023-00452-x

Pubmed : 37210499

 

255 - 

Long-term exposure to airborne metals and risk of cancer in the French cohort Gazel

Emeline Lequy, Sébastien Leblond, Jack Siemiatycki, Caroline Meyer, Danielle Vienneau et al.

Environment International, 2023, 177, pp.107999.

DOI : https://doi.org/10.1016/j.envint.2023.107999

Pubmed : 37269719

 

256 - 

Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies

Alain Lescoat, David Roofeh, Masataka Kuwana, Robert Lafyatis, Yannick Allanore et al.

Clinical Reviews in Allergy and Immunology, 2023, 64 (3), pp.239-261.

DOI : https://doi.org/10.1007/s12016-021-08891-0

Pubmed : 34468946

 

257 - 

Ultrasound classification of finger pulp blood flow in patients with systemic sclerosis: A pilot study

Alain Lescoat, François Robin, Nicolas Belhomme, Alice Ballerie, Marine de Saint Riquier et al.

Arthritis Care and Research, 2023, 75 (2), pp.299-306.

DOI : https://doi.org/10.1002/acr.24779

Pubmed : 34477332

 

258 - 

Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches

Alain Lescoat, Hiroshi Kato, John Varga

Current Opinion in Rheumatology, 2023,

DOI : https://doi.org/10.1097/BOR.0000000000000970

Pubmed : 37650691

 

259 - 

Effects of different amosite preparations on macrophages, lung damages, and autoimmunity

Alain Lescoat, Riccardo Leinardi, Kevin Pouxvielh, Yousof Yakoub, Marie Lelong et al.

Journal of Molecular Medicine, 2023, Journal of Molecular Medicine (berlin, Germany),

DOI : https://doi.org/10.1007/s00109-023-02401-9

Pubmed : 38015242

 

260 - 

Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine

Alain Lescoat, Silvia Bellando-Randone, Corrado Campochiaro, Francesco del Galdo, Christopher P Denton et al.

The Lancet Rheumatology, 2023, 5 (11), pp.e683-e694.

DOI : https://doi.org/10.1016/S2665-9913(23)00212-6